Independent Advisor Alliance’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$741K Sell
1,399
-34
-2% -$15.7K 0.02% 540
2026
Q1
$688K Sell
1,433
-1
-0.1% -$512 0.01% 993
2025
Q4
$805K Buy
1,434
+390
+37% +$221K 0.02% 529
2025
Q3
$537K Buy
1,044
+34
+3% +$14.8K 0.01% 600
2025
Q2
$317K Buy
1,010
+10
+1% +$3K 0.01% 707
2025
Q1
$305K Sell
1,000
-11
-1% -$3.7K 0.01% 655
2024
Q4
$336K Buy
1,011
+70
+7% +$23.7K ﹤0.01% 1092
2024
Q3
$314K Buy
941
+135
+17% +$51.3K 0.01% 555
2024
Q2
$332K Buy
806
+128
+19% +$50.7K 0.01% 547
2024
Q1
$274K Buy
+678
New +$238K 0.01% 592

Other funds holding MEDP

Independent Advisor Alliance's MEDP Position: Q2 2026 in Review

Independent Advisor Alliance reduced its Medpace (MEDP) stake by 2.4% in Q2 2026, selling an estimated $15.7K and leaving 1,399 shares worth $741K. The position accounts for 0.02% of the portfolio, ranked #540.

Independent Advisor Alliance first reported a position in MEDP in Q1 2024 and has held it in 10 quarters since. The position peaked at $805K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Independent Advisor Alliance held 1,399 shares of Medpace worth $741K as of Q2 2026.
  • Independent Advisor Alliance sold 34 Medpace shares in Q2 2026, an estimated $15.7K.
  • Medpace made up 0.02% of Independent Advisor Alliance's portfolio in Q2 2026, its #540 holding.
  • Independent Advisor Alliance first reported a position in Medpace in Q1 2024 and has held it in 10 quarters since.
  • Independent Advisor Alliance's Medpace position peaked at $805K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Independent Advisor Alliance's 13F filing for Q2 2026, filed 12 Aug 2026.